维普中文期刊产品整合服务
71篇 您的检索式:作者名="Gejyo F"
    题名 作者 年代 出处 被引量
1Arresting dialysis-related amyloidosis:a prospective multicenter controlled trial of direct hemoperfusion with a beta2-microglobulin adsorption column显示文摘Gejyo F Kawaguchi Y Hara S 2004Artif Organs2004,28,4:1
2Current clinical and pathogenetic understanding of beta2-m amyloidosis in long-term haemodialysis patients显示文摘Gejyo F Narita I 2003Nephrology2003,,:1
3Impacts of recombi- nant human erytbropnietin treatment during predialysis periods on the progression of chronic kidney disease in a large-scale cohort study (Co-JET study) 显示文摘AKIZAWA T SAITO A GEJYO F 2014Ther Apher Dial2014,18,2:1
4Current clinical aspects of dialysis - related amyloidosis in chronic dialysis patients显示文摘Saito A Gejyo F 2006Ther Apher Dial2006,10,4:1
5Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy显示文摘KIMURA H GEJYO F SUZUKI Y 1998Kidney International1998,54,5:1
6Elevation of serum CA19-9 levels in benign diseases显示文摘Ito S Gejyo F 1999Internal Medicine1999,,11:1
7Arresting dialysis-related amy- loidosis : A prospective multicenter controlled trial of direct hemoper- fusion with a beta 2-microglobulin adsorption column 显示文摘Gejyo F Kawaguchi Y Hara S 2004Artif Or- gans2004,28,4:1
8Polymorphisms of angiotensin coverting enzyme and plasminogen activator inhibitor-1 gene in diabetes and macroangiopathy显示文摘 Gejyo F Suzuki Y 1998Kidney Int1998,54,:1
9Dialysis-related anyloidasis and clinical significance of extracorporeal removal of beta 2 microglibulin显示文摘Gejyo F Suzuki S Arakaua M 1997Ther Apher1997,1,12:1
10Role of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism显示文摘Kazama JJ Gejyo F Shigematsu T 2005Ther Apher Dial2005,9,4:1
11Complete amino acid sequence of human plasma Zn-a2-glycoprotein and its homology to histocompati-bility antigens显示文摘Araki T Gejyo F Takagaki K 1988Proe Natl Acad Sci U S A1988,85,3:1
12Osteoelastogenesis and osteoclast activation in dialysis-related amyloidosteopathy 显示文摘Kazama JJ Maruyama H Gejyo F 2001J Kidney Dis2001,38,1:1
13Apolipoprotein E phenotypes in hemodialysis patients显示文摘 Kimura H Gejyo F 1999Kidney Int1999,56,71:1
14The C677T methylenetetra- hydrofolate reduetase gene mutation in hemndialysis patients 显示文摘Kimura H Gejyo F Suzuki S 2000J Am Soc Nephrol2000,11,5:1
15Polymorphisms of angiotens in converting enzyme and plasminogen activator inhibitor-1 gene in diabetes and macroagiopathy显示文摘Kimura H Gejyo F Suzuki Y 1998Kidney Int1998,54,5:1
16Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy显示文摘Kimura H Gejyo F Suzuki Y 1998Kidney Int1998,54,5:1
17Primary localized amyloidosis of the bladder:a case of AL(lambda) amyloid protein and combination therapy using dimethyl sulfoxide and cepharanthin显示文摘Nishiyama T Gejyo F Katayama Y 1992Urol Int1992,48,2:1
18A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2-microglobulin显示文摘Gejyo F Yamada T Odani S 1985Biochem Biophys Res Commun1985,129,:1
19Role of IgA, IgG, and IgM antibodies against Haemophilus parainfluenzae antigens in IgA nephropathy 显示文摘Suzuki S Gejyo F Nakatomi Y 1996Clin Nephrol1996,46,5:1
20Current clinical and pathogenetic un- derstanding of beta2-mamyloidosis in long-term hemodi- alysis patients显示文摘Gejyo F Narita I 2003Nephrology2003,8,1:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费